-transparent.png){kind=logo}
Although it appears that progress is being made in the treatment of breast cancers of all stages, the etiological agents still remain unclear and render the search for preventive agents extremely difficult. What is clearly required in this situation is a nontoxic compound that can potentially affect various pathways that may be responsible for the rising incidence of breast cancer. In this review, we present the rationale for the use of an agent such as calcium glucarate, which may both change the internal hormonal milieu and also directly detoxify any environmental agents responsible for breast cancer. It is hoped that present and future clinical trials will help to better elucidate the role for this agent in the chemoprevention of breast cancer.
A S Heerdt, and
C W Young, and
P I Borgen
September 2007,
Annals of the New York Academy of Sciences,
A S Heerdt, and
C W Young, and
P I Borgen
February 2011,
Nuclear medicine and biology,
A S Heerdt, and
C W Young, and
P I Borgen
January 2023,
International journal of nanomedicine,
A S Heerdt, and
C W Young, and
P I Borgen
January 1993,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
A S Heerdt, and
C W Young, and
P I Borgen
January 1993,
Anticancer research,
A S Heerdt, and
C W Young, and
P I Borgen
August 2017,
Cancer causes & control : CCC,
A S Heerdt, and
C W Young, and
P I Borgen
August 2002,
Alternative medicine review : a journal of clinical therapeutic,
A S Heerdt, and
C W Young, and
P I Borgen
April 2008,
Cancer letters,
A S Heerdt, and
C W Young, and
P I Borgen
May 2001,
Mutation research,
A S Heerdt, and
C W Young, and
P I Borgen
January 2002,
Urologic oncology,
